Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium.

Kaladchibachi SA, Doble B, Anthopoulos N, Woodgett JR, Manoukian AS.

J Circadian Rhythms. 2007 Feb 12;5:3.

PMID: 17295926 [PubMed]

Related Articles Free article in PMC

Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.

Padiath QS, Paranjpe D, Jain S, Sharma VK.

Chronobiol Int. 2004 Jan;21(1):43-55.

PMID: 15129823 [PubMed - indexed for MEDLINE]

Related Articles

Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.

Ikonomov OC, Manji HK.

Am J Psychiatry. 1999 Oct;156(10):1506-14. Review.

PMID: 10518159 [PubMed - indexed for MEDLINE]

Related Articles

A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.

Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C, Smeraldi E.

Neurosci Lett. 2004 Jan 23;355(1-2):37-40.

PMID: 14729229 [PubMed - indexed for MEDLINE]

Related Articles

Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila.

Dokucu ME, Yu L, Taghert PH.

Neuropsychopharmacology. 2005 Dec;30(12):2216-24.

PMID: 15956996 [PubMed - indexed for MEDLINE]

Related Articles

A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.

Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E.

Neurosci Lett. 2004 Sep 23;368(2):123-6.

PMID: 15351432 [PubMed - indexed for MEDLINE]

Related Articles

Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.

Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C, Smeraldi E.

Neurosci Lett. 2005 Mar 7;376(1):51-5. Epub 2004 Dec 10.

PMID: 15694273 [PubMed - indexed for MEDLINE]

Related Articles

Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.

Gould TD, Manji HK.

Neuropsychopharmacology. 2005 Jul;30(7):1223-37. Review.

PMID: 15827567 [PubMed - indexed for MEDLINE]

Related Articles

The role of circadian clock genes in mental disorders.

Lamont EW, Legault-Coutu D, Cermakian N, Boivin DB.

Dialogues Clin Neurosci. 2007;9(3):333-42. Review.

PMID: 17969870 [PubMed - indexed for MEDLINE]

Related Articles

The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.

Plattner F, Angelo M, Giese KP.

J Biol Chem. 2006 Sep 1;281(35):25457-65. Epub 2006 Jun 27.

PMID: 16803897 [PubMed - indexed for MEDLINE]

Related Articles

Lithium lengthens circadian period in a diurnal primate, Saimiri sciureus.

Welsh DK, Moore-Ede MC.

Biol Psychiatry. 1990 Jul 15;28(2):117-26.

PMID: 2116188 [PubMed - indexed for MEDLINE]

Related Articles

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Jope RS, Roh MS.

Curr Drug Targets. 2006 Nov;7(11):1421-34. Review.

PMID: 17100582 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Mania-like behavior induced by disruption of CLOCK.

Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, Vitaterna MH, Orsulak P, Takahashi JS, Nestler EJ, Carlezon WA Jr, McClung CA.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6406-11. Epub 2007 Mar 22.

PMID: 17379666 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

CK1 and GSK3 in the Drosophila and mammalian circadian clock.

Harms E, Young MW, Saez L.

Novartis Found Symp. 2003;253:267-77; discussion 102-9, 277-84.

PMID: 14712927 [PubMed - indexed for MEDLINE]

Related Articles

Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium.

Aghdam SY, Barger SW.

Curr Alzheimer Res. 2007 Feb;4(1):21-31. Review.

PMID: 17316163 [PubMed - indexed for MEDLINE]

Related Articles

Molecular effects of lithium.

Quiroz JA, Gould TD, Manji HK.

Mol Interv. 2004 Oct;4(5):259-72. Review.

PMID: 15471909 [PubMed - indexed for MEDLINE]

Related Articles

Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.

Kozikowski AP, Gaisina IN, Yuan H, Petukhov PA, Blond SY, Fedolak A, Caldarone B, McGonigle P.

J Am Chem Soc. 2007 Jul 4;129(26):8328-32. Epub 2007 Jun 7.

PMID: 17552518 [PubMed - indexed for MEDLINE]

Related Articles

Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine.

Roh MS, Eom TY, Zmijewska AA, De Sarno P, Roth KA, Jope RS.

Biol Psychiatry. 2005 Feb 1;57(3):278-86.

PMID: 15691529 [PubMed - indexed for MEDLINE]

Related Articles

Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential.

Min WW, Yuskaitis CJ, Yan Q, Sikorski C, Chen S, Jope RS, Bauchwitz RP.

Neuropharmacology. 2008 Oct 14. [Epub ahead of print]

PMID: 18952114 [PubMed - as supplied by publisher]

Related Articles

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.

Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, Cleary ML.

Nature. 2008 Oct 30;455(7217):1205-9. Epub 2008 Sep 17.

PMID: 18806775 [PubMed - in process]

Related Articles